Key Drivers, Restraints, and Opportunities in the U.S. Allergy and Autoimmune Disease Diagnostics Market
The U.S. allergy and autoimmune disease diagnostics market, valued at USD 4.24 billion in 2024, is anticipated to register a compound annual growth rate (CAGR) of 8.5% from 2025 to 2034, driven by rising prevalence of allergic and autoimmune conditions, increasing patient awareness, and the integration of advanced diagnostic technologies into clinical workflows. Allergy...
0 Commentarios 0 Acciones 44 Views 0 Vista previa